Solventum currently has a consensus target price of $79.86, indicating a potential upside of 10.24%. As a group, “Surgical & medical instruments” companies have a potential upside of 34.78% ...

Solventum presently has a consensus price target of $79.86, suggesting a potential upside of 7.46%. As a group, “Surgical & medical instruments” companies have a potential upside of 31.83%.

Shares of Solventum rose Tuesday after the company agreed to sell its filtration and purification business to medical device maker Thermo Fisher Scientific for $4.1 billion. Solventum Chief ...

Solventum Corp., 3M’s medtech spinoff, has sold its purification and filtration business to Massachussetts-based Thermo Fisher Scientific for approximately $4.1 billion. Solventum Corp. (NYSE ...

It’s been almost a year since Solventum spun off as a separate business from 3M. Now, Solventum is orchestrating a spinoff of its own. On Tuesday, Solventum announced that it has lined up a deal ...

In the final days of November, I was getting slightly concerned about a long position in Solventum Corporation (NYSE:SOLV) after shares had enjoyed a partial re-rating. By now, the healthcare spin ...

“Trian commends Solventum on the announced sale of its Purification & Filtration business and believes this is an important first step in the Company’s value creation journey. We believe that ...

MAPLEWOOD, Minn. (AP) — MAPLEWOOD, Minn. (AP) — Solventum Corp. (SOLV) on Thursday reported fourth-quarter net income of $30 million. The Maplewood, Minnesota-based company said it had net ...

Feb 27 (Reuters) - 3M spin-off Solventum (SOLV.N), opens new tab forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization ...

Diversified healthcare company Solventum (NYSE:SOLV) reported fourth-quarter 2024 earnings on Thursday, Feb. 27, that topped analysts' consensus estimates. Adjusted EPS for the quarter came in at ...

Solventum (SOLV) announced it has entered into a definitive agreement to sell its Purification & Filtration business to Thermo Fisher Scientific (TMO) for $4.1B. Solventum expects the transaction ...